WO2008020739A2 - METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM - Google Patents

METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM Download PDF

Info

Publication number
WO2008020739A2
WO2008020739A2 PCT/MN2006/000001 MN2006000001W WO2008020739A2 WO 2008020739 A2 WO2008020739 A2 WO 2008020739A2 MN 2006000001 W MN2006000001 W MN 2006000001W WO 2008020739 A2 WO2008020739 A2 WO 2008020739A2
Authority
WO
WIPO (PCT)
Prior art keywords
buffer
thrombin
tris hcl
enzyme
column
Prior art date
Application number
PCT/MN2006/000001
Other languages
French (fr)
Russian (ru)
Other versions
WO2008020739A3 (en
Inventor
Georgiy Volkov
Alexiy Savchuk
Vitaly Karbovskyy
Original Assignee
Wisdom Asset Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisdom Asset Company filed Critical Wisdom Asset Company
Publication of WO2008020739A2 publication Critical patent/WO2008020739A2/en
Publication of WO2008020739A3 publication Critical patent/WO2008020739A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/58Reptiles

Definitions

  • the invention relates to the industry of bioactive substances and can be used in biotechnological industries, medicine and the pharmaceutical industry, namely the production of medicines and diagnostic preparations from snake venom.
  • An ⁇ -specific thrombin-like enzyme cleaves fibrinopeptides A from fibrinogen, thereby participating in the formation of desAA fibrin.
  • the only source of thrombin-like enzymes are snake venoms.
  • the composition of the poison in different snakes varies, this is due to the species specificity of the poisons, as well as to the habitat and living conditions.
  • a known method for producing thrombin-like enzymes from raw venom of snakes of the genus Agististop (Solovyov D.A., Ugarova T.P. Isolation and characterization of ⁇ -specific thrombin-like enzymes from venom of common thyroid muzzle . -1993- t.58 -N8.C.1221-1233) in which the source of raw materials is the venom of snakes Agstistopod halus halus and Agstistopot blothoffiii.
  • the method includes dissolving the poison in a buffer solution and subsequent purification using sorbent-cybacron agarose.
  • the protein yield of the active fraction is 1.1-5.1%.
  • a known method for producing thrombin-like enzymes from Agistrodop asiatica poison in which the poison dissolved in the buffer is chromatographed on DEAE-Sepharose, Sephacryl S-200 and CM-Sepharose (Huapg Q., Teng M., Niu L. Purifacitum aprophota -slottipg ezproms frive-rasscher spake (Agkistrodop asitis) vepom., Tohisop. -1999. -V.37, N7. -P.999-1013)
  • a method for producing thrombin-like enzymes from Agistrodop asiatica poison in which the poison dissolved in the buffer is subjected to separation of a DEAE Sephadex A-50 anion exchanger, then chromatographed twice on Sephadex G-200 (Quapg C, Hopg J. et al. -Like rripsyler of Agkistrodop asipis vpom apd its comraritiop with bvipe thrombi., Thromb.Diath.hayemorrth -1971. -V.26 -P.224-234).
  • Heparin-Sepharose CL-6B grade of sodium chloride NaCl 0.1-0.3; 0.5M
  • Sephadex G-100 grade of sodium chloride NaCl 0.1-0.3; 0.5M
  • a known method is characterized by the fact that the poison dissolved in the buffer solution is subjected to stepwise chromatography on Sephadex G-IOO, on a SM-Touorerl 650M cation exchanger with a linear gradient of sodium chloride concentration and a full gradient volume, which provide the most complete identification and separate elution of thrombin-like enzymes, then separate rechromatography of these enzymes, setting linear gradients of sodium chloride concentration from elution conditions of the corresponding thrombus-like enzyme in the previous e while increasing the total volume of these gradients to levels which provides additional separation of adjacent thrombin enzyme to give the desired product in a homogeneous condition after the separate cleaning enzyme thrombin on the sorbent ABA-TSK. (RU 2271219 Cl (2004123274/15, 07.28.2004) 10.03.2006 Bull.7., Method for producing thrombin-like enzymes from snake venom).
  • a method for purification of thrombin-like proteases from snake venom in which the protease in the form of a crude product is subjected to preliminary purification using affinity chromatography on basic ion exchangers and the obtained fraction is subjected to chromatography on weak cation exchangers or separated by adsorption on glass in the main region.
  • WO 97/32015 PCT / EP97 / 00755
  • Method of perfection of thrombose of neck of perfume of from spike of vopom Method of perfection of thrombose of neck of perfume of from spike of vopom.
  • the closest to the achieved positive result is the method of obtaining thrombin-like enzymes from snake venom, which is characterized by the fact that in chromatographic purification of snake venom, identification and displacement of fractions containing thrombin-like enzyme, followed by isolation of the target product by chromatography on Sercharos, equilibrated with TPIC-HC1 buffer , while the poison of the snake Agistrodop halus in a 0.05M sodium chloride solution is chromatographed on a column filled with Serhasrul S-300 HR, after identification and mixing of stocks with a thrombin-like enzyme they are concentrated by ultrafiltration with selection by molecular weight SC, the resulting solution is chromatographed on a column with DEAE Serharose FF, balanced with acetate buffer solution, fractions with a thrombin-like enzyme are collected and mixed, re-concentrated by ultrafiltration, then the concentrate is chromatographed on a SP Serharose FF gel column, the fractions containing the
  • the disadvantage of the prototype is both a low level of profitability of the production process, a low level of purity and a large investment of time.
  • the basis of the invention is the task to develop a method for the isolation of a thrombin-like enzyme (ANCISTRON-B) from Agistrodop Yothoffii poison, allowing, by means of affinity chromatography and the use of carriers with higher chromatographic properties and physico-chemical stability, to increase the profitability of the production process, to shorten the time for thrombin isolation enzyme and increase its purity.
  • ANCISTRON-B thrombin-like enzyme
  • affinity chromatography is carried out using a stepwise gradient of sodium chloride, using 1OmM Tris HCl with pH 7.4 as a buffer solution containing 0.5M NaCl and the indicated solution with a concentration of sodium chloride 2M as eluent in the first stage.
  • the protein peak containing thrombin-like activity is collected, concentrated, and applied in order to change the buffer onto a column with Serhadex G 25 balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.13 M NaCl.
  • Example 1 The problem is solved by the proposed method, when the parameters of the process of isolation of a thrombin-like enzyme are in the range specified in the claims. When the parameters are changed in the direction of increasing or decreasing, the characteristics of the resulting preparation worsen.
  • the invention is illustrated by examples 1-3 of a specific implementation. Example 1
  • the solution of the poison is applied to a column (C 10/10, volume 7 ml) with an affinity sorbent Vlie Serharose FF, previously equilibrated with 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 (column equilibration rate of 2 ml / min, poison application rate 0.5 ml / min )
  • 150 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through the column.
  • the optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min.
  • the protein peak containing thrombin-like activity is collected (100 ml), concentrated to 30 ml and, with the aim of changing the buffer, it is applied to a column with Serhadex G 25 (column size 2.5x27cm, volume 120ml), equilibrated with 5OmM Tris HCl buffer with pH 7.4 containing 0.1 ZM NaCl at a rate of 5 ml / min.
  • the optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech).
  • the fraction containing Antsistron (48 ml) is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization. Characteristic Yield, mg 4.2 mg (8.4%)
  • Example 2 To 110 mg of Far Eastern mollusk venom add 5.1 ml of 1OmM Tris HCl buffer with a pH of 7.4 and move until the poison is completely dissolved at 4 0 C. Dissolved venom centrifuged at 5000 rpm at 4 0 C for 15 minutes The precipitate is discarded and the supernatant is used for affinity chromatography.
  • the solution of the poison is applied to a column (C 10/10, volume 7 ml) with an affinity sorbent Vlie Serharose FF, previously equilibrated with 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 (column equilibration rate of 2 ml / min, poison application rate 0.5 ml / min )
  • 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 columnumn equilibration rate of 2 ml / min, poison application rate 0.5 ml / min
  • 165 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 55 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through a column.
  • the optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min.
  • the protein peak containing thrombin-like activity is collected (110 ml), concentrated to 32 ml and, in order to change the buffer, it is applied to a column with Serdex G 25 (column size 2.5x27 cm, volume 120 ml), balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.1 ZM NaCl at a rate of 5 ml / min.
  • the optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech).
  • the fraction containing Antsistron 45 ml is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization.
  • 170 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 45 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through a column.
  • Optical density was recorded continuously using a flow monitor REC 120 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min.
  • the protein peak containing thrombin-like activity is collected (89 ml), concentrated to 26 ml and, with the aim of changing the buffer, it is applied to a column with Serhadex G 25 (column size 2.5x27 cm, volume 120 ml), balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.13 M NaCl with 5 ml / min.
  • the optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech).
  • the fraction containing Antsistron (50 ml) is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization.

Abstract

The invention relates to producing bioactive substances and can be used for biotechnological processes, in medicine and in the pharmacological industry, in particular to producing medicinal and diagnosis preparations from snake venom. The inventive method consists in carrying out affinity chromatography using a sodium chloride step gradient, wherein, at the first stage, 10mM Tris HCl with a pH of 7.4 is used in the form of a buffer solution and said solution having a sodium chloride concentration of 2M is used in the form of an eluent. The albumin peak exhibiting trombin-like activity is collected, concentrated and, with a view to substitutea buffer, is applied to a column with Sephadex G 25 which is balanced by a 50mM Tris HCl buffer with a pH of 7.4 and a 0.13 M NaCl content.

Description

Название изобретения: Title of invention:
Способ выделения α-специфического тромбиноподобного фермента (АНЦИСТРОН-В) из яда Аgкistrоdоп blотhоffii иssиriепsisThe method of isolation of the α-specific thrombin-like enzyme (ANCISTRON-B) from Agistrodop blotchoffii and syriepsis venom
МПК: А 61 К 35/588 IPC: A 61 K 35/58 8
Область техники к которой относится изобретенияFIELD OF THE INVENTION
Изобретение относится к промышленности биоактивных веществ и может быть использовано в биотехнологических производствах, медицине и фармацевтической промышленности, а именно к производству лекарственных и диагностических препаратов из яда змей.The invention relates to the industry of bioactive substances and can be used in biotechnological industries, medicine and the pharmaceutical industry, namely the production of medicines and diagnostic preparations from snake venom.
Уровень техники α-Специфический тромбиноподобный фермент отщепляет от фибриногена фибринопептиды А, тем самым участвует в образовании дезАА-фибрина. Единственным источником тромбиноподобных ферментов являются змеиные яды. Состав яда в различных змей варьирует, это связано с видовой специфичностью ядов, а также с местом обитания и условиям существования.BACKGROUND OF THE INVENTION An α-specific thrombin-like enzyme cleaves fibrinopeptides A from fibrinogen, thereby participating in the formation of desAA fibrin. The only source of thrombin-like enzymes are snake venoms. The composition of the poison in different snakes varies, this is due to the species specificity of the poisons, as well as to the habitat and living conditions.
Известен способ получения тромбиноподобных ферментов из сырого яда змей рода Аgкistrоdоп (Соловьев Д.A., Угарова Т.П. Выделение и храктристика α-специфических тромбиноподобных ферментов из ядов щитомордника обыкновенного {Аgкistrоdоп hаlуs hаlуs) и щитомордника восточного (среднеазиатский подвид Аgкistrоdоп blотhоffiii. Биохимия. -1993- т.58 -N8.C.1221-1233) в котором в качестве источника сырья используют яд змей Аgкistrоdоп hаlуs hаlуs и Аgкistrоdоп blотhоffiii. Способ включает растворение яда в буферном растворе и последующую очистку с использованием сорбента-цибакрон-агароза. Выход активной фракции по белку составляет 1.1-5.1%.A known method for producing thrombin-like enzymes from raw venom of snakes of the genus Agististop (Solovyov D.A., Ugarova T.P. Isolation and characterization of α-specific thrombin-like enzymes from venom of common thyroid muzzle . -1993- t.58 -N8.C.1221-1233) in which the source of raw materials is the venom of snakes Agstistopod halus halus and Agstistopot blothoffiii. The method includes dissolving the poison in a buffer solution and subsequent purification using sorbent-cybacron agarose. The protein yield of the active fraction is 1.1-5.1%.
Известен способ получения тромбиноподобных ферментов из яда змеи Тriтеrеsиrиs оkiпаvепsis путем фракционирования растворенного буфером яда на Сефадексе G-IOO, хроматографии на СМ-Тоуореаrl 650M в два этапа и заключительной очистки на Mono Q геле. (Nоsе S., Shimоhigаshi Y. еt аl. Рurifiсаtiоп апd сhаrасtеrizаtiоп оf а соаgulапt епzуmе, оkiпахоbiп II, frоm Тriтеrеsиrиs окiпаvепsis (Нiтеhаbи sпаке) vепоm whiсh rеlеаsеs fibrinopeptides A апd В., Тохiсоп. -1994. -V 32, -P.1509- 1520) Выход активной фракции по белку составляет 5.15%.There is a method of obtaining thrombin-like enzymes from snake venom Triteresis oxypavepsis by fractionation of poisoned buffer with Sephadex G-IOO, chromatography on SM-Touorerl 650M in two stages and final purification on Mono Q gel. (Nose S., Shimohigashi Y. et al. Rurifiсtiop apd сhаrаsterizatiop оf а soаgulapt epzume, okіpakho-bip II, frоm Тrеtеrіsіpіs іkіpаvepsis (Ніtehаbесепесепе) fibrinopeptides A apd B., Toxisop. -1994. -V 32, -P.1509-1520) The protein yield of the active fraction is 5.15%.
Известен способ получения тромбиноподобных ферментов из сырого яда змей рода Аgкistrоdоп sахаtilis, в котором сырый яд, растворенный в буфере, подвергается поэтапному фракцированию на Q-сефарозе, Сефадексе G-75 и Mono Q геле (Коh.Y., Chung K., Кim.D. Вiосhеmiсаl сhаrасtеrizаtiоп оf а thrоmbiп-likе епzуmе апd а fibriпоlуtiс sеriпе рrоtеаsе frоm sпаkе (Аgкistrоdоп sахаtillis) vепоm., Тохiсоп. -2001. -V.39, N4. -P.555-560) Выход активной фракции по белку составляет 8.15%.A known method for producing thrombin-like enzymes from crude venom of snakes of the genus Agistrodop sakhatilis, in which raw poison dissolved in a buffer, is subjected to gradual fractionation on Q-Sepharose, Sephadex G-75 and Mono Q gel (Koh. Y., Chung K., Kim. D. Вісхемисal сhаrаsterizаtiop оf а thrоmpіp-likе уеу аn а a frіpоlūtis sеrеpe rоroteas frоm аpak (Agkistrodop sakhatillis) vіpom., Tohisv. 5.5. %
Известен способ получения тромбиноподобных ферментов из яда Аgкistrоdоп асиtиs, в котором, растворенный в буфере яд подвергают хроматографии на DЕАЕ-Сефарозе, Сефакриле S-200 и СМ-Сефарозе (Нuапg Q., Teng M., Niu L.Рurifiсаtiоп апd сhаrасtеrizаtiоп оf twо fibriпоgеп-сlоttiпg епzуmеs frоm fivе-расе sпаkе (Аgкistrоdоп асиtиs) vепоm., Тохiсоп. -1999. -V.37, N7. -P.999-1013)A known method for producing thrombin-like enzymes from Agistrodop asiatica poison, in which the poison dissolved in the buffer is chromatographed on DEAE-Sepharose, Sephacryl S-200 and CM-Sepharose (Huapg Q., Teng M., Niu L. Purifacitum aprophota -slottipg ezproms frive-raspé spake (Agkistrodop asitis) vepom., Tohisop. -1999. -V.37, N7. -P.999-1013)
Известен способ получения тромбиноподобных ферментов из яда Аgкistrоdоп асиtиs, в котором, растворенный в буфере яд подвергают разделению анионообменнике DEAE Сефадексе A-50, затем дважды хроматографируют на Сефадексе G-200 (Quуапg С, Нопg J. еt аl. Рurifiсаtiоп апd рrореrtiеs оf thе trоmbiп-likе рriпсiрlе оf Аgкistrоdоп асиtиs vепоm апd its соmраritiоп with bоviпе thrоmbiп., Тhrоmb.Diаth.hаеmоrrth -1971. -V.26 -P.224-234).A method is known for producing thrombin-like enzymes from Agistrodop asiatica poison, in which the poison dissolved in the buffer is subjected to separation of a DEAE Sephadex A-50 anion exchanger, then chromatographed twice on Sephadex G-200 (Quapg C, Hopg J. et al. -Like rripsyler of Agkistrodop asipis vpom apd its comraritiop with bvipe thrombi., Thromb.Diath.hayemorrth -1971. -V.26 -P.224-234).
Известен способ получения тромбиноподобных ферментов из сырого яда змей рода Аgкistrоdоп асиtиs, в котором растворенный в буфере (рН 7.2), яд подвергают последовательной хроматографии на Сефадексе G-75, анионообменникеA known method of producing thrombin-like enzymes from crude venom of snakes of the genus Agistrodop asites, in which the venom is dissolved in a buffer (pH 7.2), is subjected to sequential chromatography on Sephadex G-75, an anion exchanger
DЕАЕ-Сефадексе A-50 с градиентомд хлорида натрия 0.01-0.6M, сорбентеDEAE-Sephadex A-50 with a gradient of sodium chloride 0.01-0.6M, sorbent
Гепарин-Сефарозе CL-6B (градиент хлорида натрия NaCl 0.1-0.3; 0.5M) и в отдельном случае дополнительно на Сефадексе G-100. (Коmоri Y., Nikаi Т.еt аl. А соmраrаtivе studу оf сlоttiпg fасtоrs frоm thе vепоm оf Аgкistrоdоп асиtиs соllесtеd iп сhiпа апd Таiwап.,Heparin-Sepharose CL-6B (gradient of sodium chloride NaCl 0.1-0.3; 0.5M) and, in a separate case, additionally on Sephadex G-100. (Komori Y., Nikai T. et al. And the program is stud оf сlоttiпg fаtоrs frоm thе vеpom оf Аgкistrоdop асіtіs сoіlеsted іп сіпа іпап Тaiwап.,
Comp.Biochem.Physiol. -1987. -V.88B, N2. -P643-649).Comp.Biochem.Physiol. -1987. -V.88B, N2. -P643-649).
Известен способ получения тромбиноподобных ферментов из сырого яда змей Воthrорs аtrох, заключающийся в выделении тромбиноподобной фракции, способной вызывать коагуляцию фибриногена. (Ноllеmап W.H., Wеiss LJ. , thе thrоmbiп-likе епzуmе frоm Воthrорs аtrох аmiпоbепzаmidiпе-substitutеd аgаrоsе. J Вiоl.Сhеm. 1976, Маг. -25. -251(6). -P.1663-1669)A known method of producing thrombin-like enzymes from the raw poison of snakes Віthrоs аtrox, which consists in isolating a thrombin-like fraction that can cause fibrinogen coagulation. (Butlemap WH, Weiss LJ., Thеrombi-likе аbout frоm thаtors аtroh аmіpobеzamidіpe-substitutеd аgarose. J Віl.Сhem. 1976, Mag. -25. -251 (6). -P.1663-1669)
Известен способ, храктеризующий тем, что растворенный в буферном растворе яд подвергают поэтапной хроматографии на Сефадексе G-IOO, на катионообменнике СМ-Тоуореаrl 650M с линейным градиентом концентрации хлорида натрия и полным объёмом градиента, обеспечивающими наиболее полное выявление и раздельное элюирование тромбиноподобных ферментов, затем проводят раздельную рехроматографию этих ферментов, задавая линейные градиенты концентрации хлорида натрия из условий элюирования соответствующего тромбоподобного фермента на предыдущем этапе при одновременном увеличении полных объемов этих градиентов до уровня, обеспечивающего дополнительное разделение соседных тромбиноподобных ферментов и получают целевой продукт в гомогенном состоянии после раздельной очистки тромбиноподобных ферментов на сорбенте ABA-TSK. (RU 2271219 Cl (2004123274/15, 28.07.2004) 10.03.2006 Бюл.7., Способ получения тромбиноподобных ферментов из яда змеи).A known method is characterized by the fact that the poison dissolved in the buffer solution is subjected to stepwise chromatography on Sephadex G-IOO, on a SM-Touorerl 650M cation exchanger with a linear gradient of sodium chloride concentration and a full gradient volume, which provide the most complete identification and separate elution of thrombin-like enzymes, then separate rechromatography of these enzymes, setting linear gradients of sodium chloride concentration from elution conditions of the corresponding thrombus-like enzyme in the previous e while increasing the total volume of these gradients to levels which provides additional separation of adjacent thrombin enzyme to give the desired product in a homogeneous condition after the separate cleaning enzyme thrombin on the sorbent ABA-TSK. (RU 2271219 Cl (2004123274/15, 07.28.2004) 10.03.2006 Bull.7., Method for producing thrombin-like enzymes from snake venom).
Предложен способ очистки тромбиноподобных протеаз из змеиного яда, в котором протеазу в виде сырого продукта подвергают предварительной очистке с помощью афинной хроматографии на основных ионообменниках и полученную фракцию подвергают хроматографии на слабых катионообменниках или разделяют с помощью адсорбции на стекле в основной области. (WO 97/32015 (PCT/EP97/00755) Меthоd оf рurifуiпg thrоmbiп Шее рrоtеаsе епzуmеs оbtаiпеd frоm sпаkе vёпоm).A method for purification of thrombin-like proteases from snake venom is proposed, in which the protease in the form of a crude product is subjected to preliminary purification using affinity chromatography on basic ion exchangers and the obtained fraction is subjected to chromatography on weak cation exchangers or separated by adsorption on glass in the main region. (WO 97/32015 (PCT / EP97 / 00755) Method of perfection of thrombose of neck of perfume of from spike of vopom).
Наиболее близким по достигаемому положительному результате является способ получения тромбиноподобных ферментов из яда змей является способ храктеризующий тем, что в хроматографической очистке яда змеи, идентификации и смещивания фракций, содержащих тромбиноподобных фермент, с последующим выделением целевого продукта хроматографией на Sерhаrоsе, уравновешенной TPИC-HC1 буферным раствором, при этом яд змеи Аgкistrоdоп hаlуs в 0.05M растворе натрия хлорида хроматографирует на колонке заполненной Sерhасrуl S-300 HR, после идентификации и смешивания фракций с тромбиноподобным ферментом их концентрируют ультрафилтрацией с отбором по молекулярной массе ЮКд, полученный раствор хроматографируют на колонке с DEAE Sерhаrоsе FF, уравновешенной ацетатным буферным раствором, отбирают и смешивают фракции с тромбиноподобным ферментом, повторно концентрируют ультрафильтрацией, затем концентрат хроматографируют на колонке с гелом SP Sерhаrоsе FF, фракций, содержащие целевой продукт, объединяют, разводят дистилированной водой до активности 12-15 с в тесте тромбинового времени, вносят сахарозу, азид натрия до 0.01%, разливают во флаконы и лиофильно высушивают. (RU 2 262 947C2 (2002120163/15, 24.07.2002) Способ получения тромбиноподобного коагулирующего фермента).The closest to the achieved positive result is the method of obtaining thrombin-like enzymes from snake venom, which is characterized by the fact that in chromatographic purification of snake venom, identification and displacement of fractions containing thrombin-like enzyme, followed by isolation of the target product by chromatography on Sercharos, equilibrated with TPIC-HC1 buffer , while the poison of the snake Agistrodop halus in a 0.05M sodium chloride solution is chromatographed on a column filled with Serhasrul S-300 HR, after identification and mixing of stocks with a thrombin-like enzyme they are concentrated by ultrafiltration with selection by molecular weight SC, the resulting solution is chromatographed on a column with DEAE Serharose FF, balanced with acetate buffer solution, fractions with a thrombin-like enzyme are collected and mixed, re-concentrated by ultrafiltration, then the concentrate is chromatographed on a SP Serharose FF gel column, the fractions containing the target product are combined, diluted with distilled water to 12-15 s in a thrombin time test, sucrose, sodium azide are added up to 0.01%, poured into vials and freeze-dried. (RU 2 262 947C2 (2002120163/15, 07.24.2002) A method for producing a thrombin-like coagulating enzyme).
Недостатком прототипа является как низкий уровень рентабельности производственного процесса, низкий уровень чистоты и большой затрат времени.The disadvantage of the prototype is both a low level of profitability of the production process, a low level of purity and a large investment of time.
Сущность изобретенияSUMMARY OF THE INVENTION
В основу изобретения поставлена задача разработать способ выделения тромбиноподобного фермента (АНЦИСТРОН-В) из яда Аgкistrоdоп Ыотhоffii иssиriепsis, позволяющий путём проведения афинной хроматографии и применения носителей, обладающих более высокими хроматографическими свойствами и физико-химической стабилностью, повысить рентабельность производственного процесса, сократить время выделения тромбиноподобного фермента и повысить его чистоту.The basis of the invention is the task to develop a method for the isolation of a thrombin-like enzyme (ANCISTRON-B) from Agistrodop Yothoffii poison, allowing, by means of affinity chromatography and the use of carriers with higher chromatographic properties and physico-chemical stability, to increase the profitability of the production process, to shorten the time for thrombin isolation enzyme and increase its purity.
Поставленная задача решается в том, что аффинную хроматографию проводят используя ступенчатый градиент хлористого натрия, используя на первый стадии в качестве буферного раствора 1OmM Тris HCl с рН 7.4, содержащий 0.5M NaCl и указанный раствор с концентрацией хлорида натрия 2M в качестве элюента. Белковый пик содержащий тромбиноподобную активность, собирают, концентрируют и с целью смена буфера наносят на колонку с Sерhаdех G 25, уравновешенную 5OmM Тris HCl буфером с рН 7.4 с содержанием 0.13 M NaCl.The problem is solved in that affinity chromatography is carried out using a stepwise gradient of sodium chloride, using 1OmM Tris HCl with pH 7.4 as a buffer solution containing 0.5M NaCl and the indicated solution with a concentration of sodium chloride 2M as eluent in the first stage. The protein peak containing thrombin-like activity is collected, concentrated, and applied in order to change the buffer onto a column with Serhadex G 25 balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.13 M NaCl.
Осуществление изобретенияThe implementation of the invention
Поставленная задача решается предлагаемым способом, когда параметры процесса выделения тромбиноподобного фермента находятся в переделах, указанных в формуле изобретения. При изменении параметров в сторону увеличения или уменьшения характеристики получаемого препарата ухудшаются. Изобретение иллюстрируется примерами 1-3 конкретного осуществления. Пример.1The problem is solved by the proposed method, when the parameters of the process of isolation of a thrombin-like enzyme are in the range specified in the claims. When the parameters are changed in the direction of increasing or decreasing, the characteristics of the resulting preparation worsen. The invention is illustrated by examples 1-3 of a specific implementation. Example 1
К 100мг яда щитомордника дальневосточного добавляют 5мл 1OmM Тris HCl буфера с рН 7,4 и перемешивают до полного растворения яда при 40C. Растворенный яд центрифугируют при 5000 об/мин при 40C в течении 15 мин. Осадок отбрасывают а надосадочную жидкость используют для афинной хроматографии. Раствор яда наносят на колонку (С 10/10, объём 7мл) с афинным сорбентом Вlие Sерhаrоsе FF, предварительно уравновешенную 50мл 1OmM Тris HCl буфером с рН 7,4 (скорость уравновешивания колонки 2 мл/мин, скорость нанесения яда 0,5мл/мин). После нанесения, через колонку пропускают 150мл 1OmM Тris HCl буфера с рН 7,4 и 50мл 1OmM Тris HCl буфера с pH7,4 с содержанием 0,5M NaCl со скоростью 2мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 102 ("Раrmасiа biоtесh"). Часть белков (свыше 45%) в данных условиях не адсорбируется на сорбенте, а Анцистрон связывается с Вlие Sерhаrоsе FF и его элюируют mМ Тris HCl с содержанием буфером с рН 7.4 с содержанием 2M NaCl со скоростью 2 мл/мин. Белковый пик содержащий тромбиноподобную активность, собирают (100мл), концентрируют до 30 мл и с целью смены буфера наносят на колонку с Sерhаdех G 25 (размер колонки 2.5x27cм, объём 120мл), уравновешенную 5OmM Тris HCl буфером с рН 7.4 с содержанием 0.1 ЗМ NaCl со скоростью 5 мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 102 ("Раrmасiа biоtесh"). Фракцию содержащую Анцистрон (48мл) собирают, розфасовывают по флаконам согласно активности (в качестве стабилизатора используют БСА (2мг/мл)) и высушивают лиофилизацией. Характеристика Выход, мг 4.2 мг (8.4%)5 ml of 1OmM Tris HCl buffer with pH 7.4 is added to 100 mg of Far Eastern thyroid muzzle venom and mixed until the venom is completely dissolved at 4 ° C. The dissolved venom is centrifuged at 5000 rpm at 4 ° C for 15 minutes. The precipitate is discarded and the supernatant is used for affinity chromatography. The solution of the poison is applied to a column (C 10/10, volume 7 ml) with an affinity sorbent Vlie Serharose FF, previously equilibrated with 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 (column equilibration rate of 2 ml / min, poison application rate 0.5 ml / min ) After application, 150 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through the column. The optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min. The protein peak containing thrombin-like activity is collected (100 ml), concentrated to 30 ml and, with the aim of changing the buffer, it is applied to a column with Serhadex G 25 (column size 2.5x27cm, volume 120ml), equilibrated with 5OmM Tris HCl buffer with pH 7.4 containing 0.1 ZM NaCl at a rate of 5 ml / min. The optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). The fraction containing Antsistron (48 ml) is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization. Characteristic Yield, mg 4.2 mg (8.4%)
Биологическая активность 35.7 NШ/мгBiological activity 35.7 NSh / mg
Степень очистки, раз 20.5The degree of purification, time 20.5
Пример 2. К 110мг яда щитомордника дальневосточного добавляют 5.1мл 1OmM Тris HCl буфера с рН 7,4 и перемещивают до полного растворения яда при 40C. Растворенный яд центрифугируют при 5000 об/мин при 40C в течении 15 мин. Осадок отбрасывают а надосадочную жидкость используют для афинной хроматографии. Раствор яда наносят на колонку (С 10/10, объём 7мл) с афинным сорбентом Вlие Sерhаrоsе FF, предварительно уравновешенную 50мл 1OmM Тris HCl буфером с рН 7,4 (скорость уравновешивания колонки 2 мл/мин, скорость нанесения яда 0,5мл/мин). После нанесения, через колонку пропускают 165мл 1OmM Тris HCl буфера с рН 7,4 и 55мл 1OmM Тris HCl буфера с pH7,4 с содержанием 0,5M NaCl со скоростью 2мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 102 ("Раrmасiа biоtесh"). Часть белков (свыше 45%) в данных условиях не адсорбируется на сорбенте, а Анцистрон связывается с Вlие Sерhаrоsе FF и его элюируют mМ Тris HCl с содержанием буфером с рН 7.4 с содержанием 2M NaCl со скоростью 2 мл/мин. Белковый пик содержащий тромбиноподобную активность, собирают (110мл), концентрируют до 32 мл и с целью смены буфера наносят на колонку с Sерhаdех G 25 (размер колонки 2.5x27cм, объём 120мл), уравновешенную 5OmM Тris HCl буфером с рН 7.4 с содержанием 0.1 ЗМ NaCl со скоростью 5 мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 102 ("Раrmасiа biоtесh"). Фракцию содержащую Анцистрон (45мл) собирают, розфасовывают по флаконам согласно активности (в качестве стабилизатора используют БСА (2мг/мл)) и высушивают лиофилизацией. ХарактеристикаExample 2. To 110 mg of Far Eastern mollusk venom add 5.1 ml of 1OmM Tris HCl buffer with a pH of 7.4 and move until the poison is completely dissolved at 4 0 C. Dissolved venom centrifuged at 5000 rpm at 4 0 C for 15 minutes The precipitate is discarded and the supernatant is used for affinity chromatography. The solution of the poison is applied to a column (C 10/10, volume 7 ml) with an affinity sorbent Vlie Serharose FF, previously equilibrated with 50 ml of 1OmM Tris HCl buffer with a pH of 7.4 (column equilibration rate of 2 ml / min, poison application rate 0.5 ml / min ) After application, 165 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 55 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through a column. The optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min. The protein peak containing thrombin-like activity is collected (110 ml), concentrated to 32 ml and, in order to change the buffer, it is applied to a column with Serdex G 25 (column size 2.5x27 cm, volume 120 ml), balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.1 ZM NaCl at a rate of 5 ml / min. The optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). The fraction containing Antsistron (45 ml) is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization. Characteristic
Выход, мг 4.4 мг (8.6%)Yield, mg 4.4 mg (8.6%)
Биологическая активность 35.0 NIН/мгBiological activity 35.0 NIH / mg
Степень очистки, раз 19.7The degree of purification, times 19.7
Пример 3.Example 3
К 97мг яда щитомордника дальневосточного добавляют 4.8мл 1OmM Тris HCl буфера с рН 7,4 и перемещивают до полного растворения яда при 40C. Растворенный яд центрифугируют при 5000 об/мин при 40C в течении 15 мин. Осадок отбрасывают а надосадочную жидкость используют для афинной хроматографии. Раствор яда наносят на колонку (С 10/10, объём 7мл) с афинным сорбентом Вlие Sерhаrоsе FF, предварительно уравновешенную 50мл 1OmM Тris HCl буфером с рН 7,4 (скорость уравновешивания колонки 2 мл/мин, скорость нанесения яда 0,5мл/мин). После нанесения, через колонку пропускают 170мл 1OmM Тris HCl буфера с рН 7,4 и 45мл 1OmM Тris HCl буфера с pH7,4 с содержанием 0,5M NaCl со скоростью 2мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 120 ("Раrmасiа biоtесh"). Часть белков (свыше 45%) в данных условиях не адсорбируется на сорбенте, а Анцистрон связывается с Вlие Sерhаrоsе FF и его элюируют mМ Тris HCl с содержанием буфером с рН 7.4 с содержанием 2M NaCl со скоростью 2 мл/мин. Белковый пик содержащий тромбиноподобную активность, собирают (89мл), концентрируют до 26мл и с целью смены буфера наносят на колонку с Sерhаdех G 25 (размер колонки 2.5x27cм, объём 120мл), уравновешенную 5OmM Тris HCl буфером с рН 7.4 с содержанием 0.13 M NaCl со скоростью 5 мл/мин. Оптическую плотность регистрируют непрерывно с помощью проточного монитора REC 102 ("Раrmасiа biоtесh"). Фракцию содержащую Анцистрон (50мл) собирают, розфасовывают по флаконам согласно активности (в качестве стабилизатора используют БСА (2мг/мл)) и высушивают лиофилизацией. Характеристика4.8 ml of 1OmM Tris HCl buffer with a pH of 7.4 is added to 97 mg of Far Eastern mollusk poison and transferred until the poison is completely dissolved at 4 0 C. The dissolved poison is centrifuged at 5000 rpm at 4 0 C for 15 minutes. The precipitate is discarded and the supernatant is used for affinity chromatography. The solution of the poison is applied to a column (C 10/10, volume 7 ml) with an affinity sorbent Vlie Serharose FF, previously equilibrated with 50 ml of 1OmM Tris HCl buffer with pH 7.4 (speed column balancing 2 ml / min, the rate of deposition of poison 0.5 ml / min). After application, 170 ml of 1OmM Tris HCl buffer with a pH of 7.4 and 45 ml of 1OmM Tris HCl buffer with a pH of 7.4 containing 0.5 M NaCl at a rate of 2 ml / min are passed through a column. Optical density was recorded continuously using a flow monitor REC 120 (Parmacia biotech). Under these conditions, part of the proteins (over 45%) is not adsorbed on the sorbent, and Ancistron binds to Vlie Serharose FF and elute with mM Tris HCl containing a buffer with a pH of 7.4 with a content of 2M NaCl at a rate of 2 ml / min. The protein peak containing thrombin-like activity is collected (89 ml), concentrated to 26 ml and, with the aim of changing the buffer, it is applied to a column with Serhadex G 25 (column size 2.5x27 cm, volume 120 ml), balanced with 5OmM Tris HCl buffer with pH 7.4 containing 0.13 M NaCl with 5 ml / min. The optical density was recorded continuously using a flow monitor REC 102 (Parmacia biotech). The fraction containing Antsistron (50 ml) is collected, packaged in vials according to activity (BSA (2 mg / ml) is used as a stabilizer) and dried by lyophilization. Characteristic
Выход, мг 3.9 мг (7.9%)Yield, mg 3.9 mg (7.9%)
Биологическая активно сть 36.2 NIН/мгBiological activity 36.2 NIH / mg
Степень очистки, раз 21.2 The degree of purification, times 21.2

Claims

Формула изобретенияClaim
Способ выделения α-специфического тромбиноподобного фермента (АНЦИСТРОН-В) из яда Аgкistrоdоп blотhоffii иssиriепsis, включающий растворение яда в буферном растворе с последующим центрифугированием, аффинной хроматографии, использующей ступенчатый градиент хлористого натрия, сбор фракций, содержащих биологическую активность α-специфического тромбиноподобного фермента и лиофилизацию отличающийся тем, что аффинную хроматографию проводят на колонке с носителем Вlие Sерhаrоsе FF, используя на первой стадии в качестве буферного раствора 1OmM Тris HCl с рН 7,4, содержащий 0,5M NaCl и указанный раствор с концентрацией хлорида натрия 2M в качестве элюента и белковый пик содержащий тромбиноподобную активность, собирают, концентрируют и с целью смены буфера наносят на колонку с Sерhаdех G 25, уравновешенную 5OmM Тris HCl буфером с рН 7.4 с содержанием 0.13 M NaCl. A method for isolating an α-specific thrombin-like enzyme (ANCISTRON-B) from Agistrodop blotchoffii and syriepsis poison, including dissolving the poison in a buffer solution followed by centrifugation, affinity chromatography using a stepwise gradient of sodium chloride, collecting fractions containing the biological activity of an α-specific enzyme and lyophil-specific characterized in that the affinity chromatography is carried out on a column with the carrier Blie Serharose FF, using, in the first stage, 1OmM Tris HCl with p 7.4, containing 0.5 M NaCl and the indicated solution with a concentration of sodium chloride 2M as an eluent and a protein peak containing thrombin-like activity, are collected, concentrated, and applied to a column with Serhadex G 25 equilibrated with 5OmM Tris HCl buffer with pH to change the buffer 7.4 with a content of 0.13 M NaCl.
PCT/MN2006/000001 2006-08-16 2006-08-30 METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM WO2008020739A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MN381506 2006-08-16
MN3815 2006-08-16

Publications (2)

Publication Number Publication Date
WO2008020739A2 true WO2008020739A2 (en) 2008-02-21
WO2008020739A3 WO2008020739A3 (en) 2008-07-24

Family

ID=39082462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MN2006/000001 WO2008020739A2 (en) 2006-08-16 2006-08-30 METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM

Country Status (1)

Country Link
WO (1) WO2008020739A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2262947C2 (en) * 2002-07-24 2005-10-27 Общество с ограниченной ответственностью фирма "Технология-Стандарт" Method for obtaining thrombin-like coagulating enzyme

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2262947C2 (en) * 2002-07-24 2005-10-27 Общество с ограниченной ответственностью фирма "Технология-Стандарт" Method for obtaining thrombin-like coagulating enzyme

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [Online] BIAN L. ET AL.: 'Three-step column chromatographic method for separation and purification of thrombin-like enzyme from venom of Agkistrodon halys pallas' Database accession no. (16830459) & SE PU vol. 24, no. 2, March 2006, pages 135 - 139 *
DATABASE MEDLINE [Online] NLI T. ET AL.: 'Purification, identification of acoagulation, an anticoagulation factor from the venom of Chinese Agkistrodon, and observation of its anticoagulation effect' Database accession no. (15257920) & DI YI JUN YI DA XUE XUE BAO vol. 24, no. 7, 2004, pages 836 - 838 *
DATABASE MEDLINE [Online] SOLOVIEV D.A. ET AL.: 'Vydelenie i kharakteristika alpha-spetsificheskikh trombinopodobnykh ferementov iz yadov schitomordnika obyknovennogo (Agkistrodon halys halys) i schitimordnika vostochnogo (sredneaziatichesky podvid Agkistrodon blomhoffii)' Database accession no. (8399770) & BIOKHIMIYA vol. 58, no. 8, 1993, pages 1221 - 1233 *
DATABASE MEDLINE [Online] SUZUKI T. ET AL.: 'Purification of two thrombin -like enzymes from the venom of Agkistrodon caliginosus (kankoku-manushi)' Database accession no. (6719476) & TOXICON. vol. 22, no. 1, 1984, pages 29 - 38 *

Also Published As

Publication number Publication date
WO2008020739A3 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
EP1927363B1 (en) An extract for preventing or treating thrombotic diseases
CN107267490A (en) For purification of Recombinant ADAMTS13 and other oroteins method with and combinations thereof
JPS62174023A (en) Anticoagulant substance, production thereof and anticoagulant agent containing said substance as active ingredient
Majumdar et al. Antiplatelet and antithrombotic activity of a fibrin (ogen) olytic protease from Bacillus cereus strain FF01
DE2734427C3 (en) Process for the recovery of thrombin-like enzymes from snake venom
Tian et al. Purification and biochemical characterization of a novel fibrinolytic enzyme, PSLTro01, from a medicinal animal Porcellio scaber Latreille
Thakur et al. Biochemical and pharmacological characterization of a toxic fraction and its cytotoxin-like component isolated from Russell's viper (Daboia russelii russelii) venom
JPH06505494A (en) Preparation of factor IX
CN113755476B (en) Preparation method and application of maggot kinase
Gomes et al. Hannahpep: a novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom
JPH06128296A (en) Method of preparing human antithrombin -iii
Yamashiro et al. Proteoforms of the platelet-aggregating enzyme PA-BJ, a serine proteinase from Bothrops jararaca venom
Lee et al. Cloning and characterization of a blood coagulation factor IX-binding protein from the venom of Trimeresurus stejnegeri
CN113789319B (en) Method for separating maggot kinase from fly maggots and application thereof
WO2008020739A2 (en) METHOD FOR EXTRACTING α-SPECIFIC TROMBIN-LIKE ENZYME (ANCISTRON-B) FROM AGKISTRODON BLOMHOFFII USSURIENSIS VENOM
CN106916803A (en) A kind of perinereis aibihitensis Grube fibrinolytic protein enzyme and its production and use
US4027012A (en) Process for the extraction of components having anticoagulant activity "in vivo" from snake venoms and products obtained
CZ269798A3 (en) Purification process of proteases, resembling to thrombin from snake venom
Sadeesh Kumar et al. Screening and characterization of fibrinolytic protease producing Bacillus circulans from mangrove sediments Pitchavaram, South East Coast of India
WO1994013807A1 (en) Clotting inhibitor made from protostomia saliva
Anangi et al. Expression of snake venom toxins in Pichia pastoris
RU2271219C1 (en) Method for production of thrombin-like enzyme from snake venom
EP0650364B1 (en) Purification of factor ix
WO2008020741A2 (en) Method for extracting phospholipase a2 from agkistrodon blomhoffii venom
WO2008020742A2 (en) Method for extracting fibrinogenic/fibrinolytic protein from agkistrodon blomhoffii ussuriensis venom

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06783791

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

NENP Non-entry into the national phase in:

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06783791

Country of ref document: EP

Kind code of ref document: A2